Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy
Fig 4
Correlations between the levels of asymmetric dimethylarginine (ADMA) and echocardiographic parameters of patients undergoing valve replacement (VR) surgery.
(A) plasma ADMA vs. area of right ventricle (y = 10.438x + 25.49, r = 0.453, p = 0.011); (B) PF ADMA vs. left ventricular (LV) end-systolic diameter (y = 23.689x + 13.53, r = 0.487, p = 0.007); (C) PF ADMA vs. LV end-diastolic diameter (y = 20.531x + 34.72, r = 0.434, p = 0.015); D: PF ADMA vs. LV ejection fraction (y = -16.779x + 73.55, r = -0.445, p = 0.013).